LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:  

• Partner with selected providers throughout Arizona in order to improve the management of liver disease.
• Increase access to tertiary care hepatobiliary services.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
 

AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 
None

All relevant financial relationships have been mitigated.

No relevant financial relationship(s) with ineligible companies: 
David Chascsa, MD, Rolland Dickson, MD, Karen Dobbins, MBA, PMP, Channa Jayasekera, MD, Blanca Lizaola-Mayo, MD, Candace Mansour, RN, and David Payton, PA-C

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None